Status:
COMPLETED
WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
ETH Zurich
Conditions:
COVID
COVID 19
Eligibility:
All Genders
18-120 years
Brief Summary
The aim is to develop a wearable-based ICU (intensive care unit) prediction algorithm for inpatients contracted with SARS-CoV-2. Inpatients with suspicion of COVID-19 or with confirmed SARS-CoV-2 infe...
Detailed Description
The SARS-CoV-2 pandemic puts an unprecedented burden on the healthcare system, specifically its healthcare providers and the resource demands for intensive care units (ICUs). To support effective care...
Eligibility Criteria
Inclusion
- Informed consent as documented by signature
- Age \>= 18 years
- Suspicion of COVID-19 or patient tested positive for SARS-CoV-2
- Hospitalisation on the general ward
Exclusion
- Smartwatch cannot be attached around the wrist of the patient
- Direct transfer from the emergency department or external institution to ICU (i.e. no hospitalization on the general ward)
- Known allergies to components of the smartwatch
- Rejection of ICU transfer in the patient decree
Key Trial Info
Start Date :
October 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04357834
Start Date
October 22 2020
End Date
June 30 2021
Last Update
August 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emergency Department, University Hospital Bern, Inselspital
Bern, Switzerland, 3010